Evaluation of a remote monitoring app in head and neck cancer follow‐up care

BACKGROUND: A remote monitoring app was developed for head and neck cancer (HNC) follow‐up during the SARS‐CoV‐2 pandemic. This mixed‐methods study provides insight in the usability and patients' experiences with the app to develop recommendations for future use. METHODS: Patients were invited to participate if they were treated for HNC, used the app at least once and were in clinical follow‐up. A subset was selected for semi‐structured interviews through purposive sampling considering gender and age. This study was conducted between September 2021–May 2022 at a Dutch university medical center. RESULTS: 135 of the 216 invited patients completed the questionnaire, resulting in a total mHealth usability score of 4.72 (± 1.13) out of 7. Thirteen semi‐structured interviews revealed 12 barriers and 11 facilitators. Most of them occurred at the level of the app itself. For example, patients received no feedback when all their answers were normal. The app made patients feel more responsible over their follow‐up, but could not fulfill the need for personal contact with the attending physician. Patients felt that the app could replace some of the outpatient follow‐up visits. CONCLUSIONS: Our app is user‐friendly, makes patients feel more in control and remote monitoring can reduce the frequency of outpatient follow‐up visits. The barriers that emerged must be resolved before the app can be used in regular HNC follow‐up. Future studies should investigate the appropriate ratio of remote monitoring to outpatient follow‐up visits and the cost‐effectiveness of remote monitoring in oncology care on a larger scale.